Search
for
Sort by
Research 811–840 of 1000+
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Melatonin-Loaded Nanocarriers: New Horizons for Therapeutic Applications
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- MoS2 Nanoclusters-based biomaterials for disease- impaired wound therapy
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Alopecia Areata After Initiation of Secukinumab Therapy for Plaque Psoriasis
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- Preclinical Results of the Potential Role of Exolight Exosomes as Adjuvant Therapy of CO2 Laser Application for Skin Aging Management
- Clinical Research Progress on Plum-Blossom Needle Combined Therapy for Androgenic Alopecia
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Integrating Psychodermatology and Platelet-Rich Plasma Therapy in Various Dermatological Conditions: A Narrative Review
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Topical sodium valproate-loaded nanospanlastics versus conventional topical steroid therapy in alopecia areata: a randomized controlled study
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- A hair growth questionnaire for use in the evaluation of therapeutic effects in men
- Overexpression of IL-18 in the Proliferative Phase Endometrium of Patients With Polycystic Ovary Syndrome
- High-performance liquid chromatographic method for the determination of finasteride in human plasma at therapeutic doses
- Response to: “Minimum requirements for reporting clinical trials evaluating the therapeutic potential of platelet-rich plasma”
- Bhringraj (Eclipta Alba): A Thorough Review Of Its Therapeutic Benefits And Uses
- Beyond Clinical Efficacy: A Literature Review on the Safety Challenges of Isotretinoin Therapy
- TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia
- Dupilumab and Alopecia Areata: A Possible Combined or Disturbance Therapy? A Review of the Literature
- Malignant epithelial tumors: Part II. Therapy and prevention
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy